. EGFR is a potential dual molecular target for cancer and Alzheimer's disease. Front Pharmacol. 2023;14:1238639. Epub 2023 Aug 2 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.